Published by Josh White on 9th February 2022
(Sharecast News) - Life sciences company OptiBiotix Health updated the market on its strategic and commercial progress on Wednesday, reporting that the next phase of its strategy would involve reinvesting proceeds from the recent sale of SkinBioTherapeutics shares, which generated £2m.
URL: http://www.digitallook.com/dl/news/story/32452536/...